Powered by

Medeon Biodesign Announces Successful Clinical Use of AbClose(TM) Laparoscopic Port Site Closure Device in the United States

Oct 20, 2017 - PR Newswire

Medeon Biodesign, Inc., a publicly traded medical device company headquartered in Taipei, is pleased to announce that its innovative laparoscopic port site closure device, AbClose(TM), successfully closed more than 50 wounds in a variety of laparoscopic surgeries. The device consistently demonstrated its simplicity, stability and predictability in the hands of multiple physicians in an ongoing pre-commercial clinical evaluation in the United States.

The U.S. Food and Drug Administration 51...